Vaccine Symposium

About this event

Sep 12, 2019
UMC Utrecht

PROGRAM MINI-SYMPOSIUM: “Structural Vaccinology”

09.30 Andrew Ward (Integrative Structural Biology, Scripps Institute, San Diego) “Using the broad resolving power of the electron microscope to drive vaccine development”

10.10 Rogier Sanders (Amsterdam UMC and Weill Cornell Medical Center, New York)

“Structure-based HIV-1 vaccine design”

10.40 Berend Jan Bosch (UU, Faculty of Veterinary Medicine) “Interrogating humoral immune responses to find key protective antibodies against coronaviruses”

11.10 Break

11.35 Hans Langedijk (Janssen, Leiden) “Stabilization of conserved metastable structural elements in class I fusion proteins for optimal vaccine design”

12.05 Joost Snijder (UU, Faculty of Science/Seattle) “Integrating MS and cryoEM to monitor glycosylation of viral antigens and its role in antigen-antibody interactions”

12.35 Robert de Vries (UU, Faculty of Science) “Understanding Influenza A virus receptor specificity is essential for H3N2 vaccine development”

13.05 Lunch

13.40 Adrian McDermott (Vaccine Research Centre NIAID, Bethesda): “The search for a universal influenza vaccine” (to be confirmed)

14.20 Henderik W. Frijlink, (RUG, Groningen Research Institute of Pharmacy) "Dry vaccines for pulmonary administration"

15.50 Break


16.15 Matthijs Raadsen (EUR Viroscience), “Clinical development of a novel vaccine for MERS coronavirus based on the Modified Vaccinia Ankara (MVA) vector“

16.30 Philip Brouwer (Amsterdam UMC) “A two-component nanoparticle vaccine candidate presenting stabilized Lassavirus glycoproteins”

16.45 Kwinten Sliepen (Amsterdam UMC) “Novel hepatitis C virus vaccine candidates based on E1E2 glycoproteins displayed on designed two-component nanoparticles”

Venue: Lecture hall Green, UMC Utrecht, Heidelberglaan 100, Utrecht
More information: Prof. Dr. W. van Eden 030 - 2534358 /